Signum Surgical, which is developing minimally invasive technologies to treat colorectal diseases, has secured two grants totalling €3.6 million: €2.3 million from the EU Horizon 2020 SME Instrument, and €1.3 million from Ireland’s Disruptive Technologies Innovation Fund.
Renal insufficiency is an expensive condition to treat due to the high cost of hospital dialysis treatment. Peripal AG, a Swiss startup, has received approval for the European market for its PeriSafe device for at-home dialysis.
MMC Ventures, which invests in AI companies, has published its State of AI 2019 report, revealing rapid recent progress in AI adoption in healthcare.
The European Commission is launching a new online knowledge-sharing platform to support better diagnosis and treatment for more than 30 million Europeans living with a rare disease.
The first EU patients can use digital prescriptions issued by their home doctor when visiting a pharmacy in another EU country. Finnish citizens are now able to retrieve medicine prescribed by a doctor in Finland from a pharmacy in Estonia with ePrescriptions.
WeHealth by Servier and Pathmaker Neurosystems have formed a partnership to develop and commercialise Pathmaker’s MyoRegulator device, a non-invasive treatment for spasticity.
JPND, the EU’s neurodegenerative disease research initiative, has announced a €30 million call for multinational research on personalised medicine for neurodegenerative diseases.